Loading clinical trials...
Loading clinical trials...
Redesigned Process in the Operating Room: Monitoring and Evaluating Success of Reducing Non Operative Time
The main purpose of the study is to examine whether operating room (OR) efficiency will be improved by significantly decreasing non operative time. This study also aims: 1) to evaluate whether a decrease in non-operative time will result in increased surgeon and staff satisfaction, 2) to determine whether there is an increase in the complication rate during the redesigned process perioperatively and until discharge from the post anesthesia care unit, and 3) to rate patient satisfaction.
The study aims to examine whether operating room efficiency will be improved by decreasing non operative time while ensuring patient safety. Patients will be randomized into one of two groups: In group A (new process): patients will be inducted in the induction room. At the end of surgery and after placement of the surgical dressing, the registered nurse will call in the house keeper to start cleaning of the OR (parallel processing) before the patient exits the room. The patient will be reversed with sugammadex 4mg/kg IV, and then extubated before being moved out of the OR. In group B (the current practice at AUBMC), patients will be treated as follows: patients will be induced in the operating room and at the end of surgery will be reversed with neostigmine 50µg/kg and glycopyrrolate 10µg/kg. Once extubated and rolled out of the room, the house keeper team will start cleaning the operating room. Induction time (IT), emergence time (ET), and turn over time (TOT) will be recorded for both groups. We expect to show that OR efficiency will be improved by significantly decreasing non operative time while ensuring patient safety.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
American University of Beirut Medical Center
Beirut, Lebanon
Start Date
May 18, 2018
Primary Completion Date
October 30, 2020
Completion Date
October 30, 2020
Last Updated
March 9, 2022
120
ACTUAL participants
Patients will be inducted in the induction room
PROCEDURE
Redesigned process
PROCEDURE
patient will be reversed with sugammadex 4mg/kg IV
DRUG
STANDARD PROCESS
PROCEDURE
Lead Sponsor
American University of Beirut Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions